Product Datasheet

 
Product Description
 
Product: Human coagulation Factor beta-XIIa
Catalog Number: HFXIIAB
Product Page: https://www.mol-innov.com/products/
Description: Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa (Cat # HFXIIA) and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is >95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I & II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease).
Recommended Storage: SAMPLE
Minimum Shelf Life: 209.00
Source: 2.0 mg/ml
Molecular Weight: Proteins
Extinction Coefficient: 30,000
Antigen: -70 C
Target: Frozen liquid
Target Molecular Weight: FACTOR XII
Host: 992.75
Clonality: 5
Isotype: Human plasma
Applications: Dry ice
Cross-reactivity: 3 years from delivery
Concentration: 220
Volume: 1045
Titer: 4 mM Sodium Acetate; 0.15 M NaCl; pH 5.3
Buffer: SAMPLE
Form: 0.1 mg
Preservative: 0.05 ml
 
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet.
 
For in vitro laboratory use only
 
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com